Alnylam Pharmaceuticals Inc. is releasing early data that shows its RNAi therapeutic technology may be able to "silence" a gene associated with Parkinson's disease. It has already happened in a pre-clinical trial, testing the technology on a group of non-human primates.
Steve Bernitz has taken the role of general partner at Cambridge-based Extera Partners, a life sciences-focused firm specializing in partnerships, acquisitions and new product commercialization.
The finite element analysis package, developed by Scientific Forming Technologies Corp., is specially designed for large deformation problems with complex contact.
The FDA is is announcing a public meeting on the reauthorization of the medical device user fee program. The current legislative authority for the medical device user fee program expires in September 2012 and new legislation will be required for FDA...
Maxon’s newly improved EC 22 motors are equipped with preloaded ball bearings and latest generation Neodymium permanent magnets.
Designed with production personnel in mind, the new Digimar 816 CL height gage from Mahr Federal provides highly accurate measurements without complicated procedures.
Posital's Magnetocode (MCD) absolute rotary encoders are available with heavy-duty stainless steel housings that make them ideal for use in harsh environments.
Biomerica Inc. said Monday it has received European regulatory approval to sell a home test that consumers can use to determine if they are allergic to dogs.The biomedical company will sell the product through drug stores and other retailers in the European Union under the Fortel Dog allergy...
Covalon Technologies Ltd. (TSXV:COV) says its third-quarter loss was cut in half, as the medical technology developer reduced costs by 40 per cent compared with the same period last year.Covalon's net loss was $647,223 in the three months ended June 30, down from $1.2 million in the...
Federal Register: Food and Drug Administration Clinical Trial Requirements, Regulations, Compliance, and Good Clinical Practice; Public WorkshopAugust 23, 2010 5:32 am | by U.S. Food & Drug Administration | News | Comments
The public workshop on FDA's clinical trial requirements is designed to aid the clinical research professional's understanding of the mission, responsibilities, and authority of FDA and to facilitate interaction with FDA representatives. The program will
Federal Register: Public Workshop on Medical Devices and Nanotechnology: Manufacturing, Characterization, and Biocompatibility ConsiderationsAugust 23, 2010 5:32 am | by U.S. Food & Drug Administration | News | Comments
The purpose of this workshop is to obtain information on manufacturing, characterization, and biocompatibility evaluation of medical devices containing or utilizing nanomaterials and nanostructures, including diagnostics. FDA is seeking input on these...
Cambridge biotech Taligen Therapeutics Inc. has added on to its Series B Round with an additional $10 million, bringing the amount up to $36 million of a planned $65 million second round.
UK. 23RD AUGUST 2010: The Panasonic Toughbook CF-C1 will bring major benefits to community healthcare workers and patients alike, claimed NHS leaders speaking at BT's unveiling of the Toughbook as a key component of its Mobile Health Worker solution.The CF-C1, a rugged yet lightweight...
(American Cancer Society) A new analysis has found that short-term and long-term costs of prostate cancer care vary considerably based on which treatment strategy a man initially receives.
(American Cancer Society) A new analysis has found that while colon cancer rates have remained steady over the past several decades among people under the age of 40, rectal cancer rates are increasing in this population across races and in both sexes.